Roche Laboratories, Nutley, N.J., is reviewing general media buying and direct media buying duties for fat-fighting drug Xenical and influenza drug Tamiflu. Media and direct agencies have received RFPs from AAR/Bob Wolf Partners, New York, regarding the assignments. Total spending is estimated at $40 million to $50 million. General and direct media buying incumbents Impiric, Media Marketing Solutions and Media Direct Partners were invited to compete, according to executives close to the review.
Copyright August 2000, Crain Communications Inc.